Please assess the completion status of the following clinical trial:

Trial Title: Treating Tuberculosis Wasting With a High-protein Supplement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed with TB~* Aged 18 years and above~* BMI\<20~Exclusion Criteria:~* Pregnancy~* Commencement of treatment ≥30 days prior to inclusion~* Decreased kidney function~* Missing informed consent~* Mentally ill/disabled patients unable to comply with the treatment/intervention regimen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): Control arm will not receive the intervention, but will receive standard 6-month anti-tuberculosis regimen and nutritional supplements provided by various NGO's (on irregular basis).
- Intervention (Type: EXPERIMENTAL): Intervention arm will receive standard 6-month anti-tuberculosis regimen, nutritional supplements provided by various NGO's (on irregular basis), and receive the study intervention of daily supplement of 62.5g Lacprodan® DI-8090

Based on this trial design, predict the completion outcome and termination type (if applicable).